Anacor (ANAC) Beats Forecasts

Anacor Pharmaceuticals, Inc. (ANAC) reported fourth quarter EPS of ($0.24) in the extended session Thursday, compared to the consensus estimate of ($0.60). Revenues increased nearly 13% from last year to $9.6 million. Analysts expected revenues of $4.73 million. The stock is currently up $2.38 to $50.90 on 680K shares. For Q4/14, the biopharmaceutical firm reported […] View the full post at: Anacor (ANAC) Beats Forecasts Related posts: Insider Selling: Twitter (TWTR) CEO Unloads $5M Worth of Stock